Test Background One molecule of Apo B lies at the core of the VLDL moiety from which the enzyme lipoprotein lipase progressively removes triglycerides to form LDL. Measurement of Apo B facilitates a stratification of risk for the development of atherosclerotic heart disease in a manner analogous to that of LDL calculation, but not fraught with the same complications, eg. hypertriglyceridaemia hampers indirect inference of LDL from HDL/triglyceride assay.
Clinical Indications Suspected hyperlipidaemia/hyperlipidaemia Family history of cardiovascular heart disease Unreliable LDL calculation, ie. consistent hypertriglyceridaemia Investigations of the suspected inborn error of metabolism Bassen-Kornzweig syndrome (Apo B deficiency: symptoms include diarrhoea, failure to thrive, neurological disorders and steatorrhoea)
Male: 0.41 - 1.06 g/L
Female: 0.47 - 0.99 g/L
Sample Required SST (gold top) or serum (red top)
Sample Volume 0.5 mL
Stable at 2-8oC for 72 hours. Please freeze pending dispatch for analysis.
Sample can be sent by first class post.
Turnaround Time 1 week
Grossly haemolysed samples are unsuitable for this assay.